Table 4:
Characteristics of participants with delivery HBV VL >200,000 IU/mL (n = 8)
| Participant | Year of delivery | HBeAg status | Mid-trimester gestational age (wk) | Mid-trimester HBV VL (IU/mL) | Delivery gestational age (wk) | Delivery HBV VL (IU/mL) | Antiviral treatment (yes or no) | Infant HBsAg status |
|---|---|---|---|---|---|---|---|---|
| 1 | 2011 | Negative | 22 | 1,570 | 38 | 1,232,032 | Unknown | Negative |
| 2 | 2012 | Positive (delivery sample) | N/A | N/A | 39 | 13,340,1162 | No | Negative |
| 3 | 2012 | Unknown | N/A | N/A | 37 | 20,745,970 | No | Negative |
| 4 | 2012 | Positive | 26 | 78,144 239 | 38 | 355,717,386 | Unknown | Unknown |
| 5 | 2012 | Positive | N/A | N/A | 40 | 290,815,045 | No | Negative |
| 6 | 2013 | Positive | N/A | N/A | 38 | 40,385,130 | Unknown | Unknown |
| 7 | 2013 | Positive | N/A | N/A | 38 | 8,159,631 | No | Negative |
| 8 | 2015 | Positive | N/A | N/A | 39 | 515,368 | No | Negative |
HBV = hepatitis B virus; VL = viral load; IU = international unit; HBeAg = hepatitis B envelop antigen; HBsAg = hepatitis B surface antigen; N/A = not available